Cargando…

Is the use of non-selective beta-blockers necessary in cirrhotic patients with small varices?

Detalles Bibliográficos
Autores principales:	Qi, Xingshun, Guo, Xiaozhong, Fan, Daiming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hellenic Society of Gastroenterology 2014
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4188952/ https://www.ncbi.nlm.nih.gov/pubmed/25331083

Ejemplares similares

Adherence to Non-Selective Beta Blockers for Prevention of Variceal Bleeding in Cirrhotic Patients
por: An, Yang, et al.
Publicado: (2021)

Use of nonselective β blockers after variceal eradication in cirrhotic patients undergoing secondary prophylaxis of esophageal variceal bleeding: a critical review of current evidence
por: Xu, Xiangbo, et al.
Publicado: (2019)

An early decision of transjugular intrahepatic portosystemic shunt may be considered for non-malignant and non-cirrhotic portal vein thrombosis with ascites: a concise review of the theoretical possibility and practical difficulty
por: Qi, Xingshun, et al.
Publicado: (2016)

Recombinant factor VIIa for variceal bleeding in liver cirrhosis: still only a hope
por: Qi, Xingshun, et al.
Publicado: (2017)

Increase in Free Hepatic Venous Pressure Response to Beta-Blockers Predicts Variceal Bleeding in Cirrhotic Patients
por: Guo, Huiwen, et al.
Publicado: (2021)

Use of Non-Selective Beta-Blocker for Refractory Stomal Variceal Hemorrhage
por: Mu, Xin, et al.
Publicado: (2021)

Cholangitis in a patient with hepatic hydatidosis
por: Qi, Xingshun, et al.
Publicado: (2012)

Transjugular intrahepatic portosystemic shunt may be superior to conservative therapy for variceal rebleeding in cirrhotic patients with non-tumoral portal vein thrombosis: A hypothesis
por: Qi, Xingshun, et al.
Publicado: (2012)

Nonselective β-Blockers May Progress the Thrombosis of Portal Venous System in Cirrhotic Patients: A Retrospective Observational Study
por: Xu, Xiangbo, et al.
Publicado: (2020)

Portal hypertension complicating myelofibrosis in a patient without portal or hepatic vein thrombosis
por: Qi, Xingshun, et al.
Publicado: (2014)

Transjugular intrahepatic portosystemic shunt for the prevention of variceal rebleeding in cirrhotic patients with portal vein thrombosis: study protocol for a randomised controlled trial
por: Qi, Xingshun, et al.
Publicado: (2013)

Variceal bleeding in cirrhotic patients
por: Mallet, Maxime, et al.
Publicado: (2017)

Pharmacologic Prophylaxis of Portal Venous System Thrombosis after Splenectomy: A Meta-Analysis
por: Qi, Xingshun, et al.
Publicado: (2014)

Early prophylaxis of cardiomyopathy with beta-blockers and angiotensin receptor blockers in patients with Duchenne muscular dystrophy
por: Lee, Heirim, et al.
Publicado: (2022)

Response to: A myth of ophthalmic beta-blockers therapy
por: Wolfs, Roger C. W.
Publicado: (2009)

Beta-blocker Rebound Phenomenon in an Adolescent with Graves’ Disease
por: Anık, Ahmet
Publicado: (2022)

Imbalance of Pro- vs. Anti-Coagulation Factors in Chinese Patients with Budd-Chiari Syndrome and Non-Cirrhotic Portal Vein Thrombosis
por: Chen, Hui, et al.
Publicado: (2015)

Specific Factors That Influence Adherence to Beta Blocker Treatment in Primary Prevention of Variceal Bleeding in Cirrhotic Romanian Patients. a Proof of Concept Qualitative Study
por: Sovaila, Silvia, et al.
Publicado: (2018)

Knowledge about non-invasive diagnostic tests for varices in liver cirrhosis: A questionnaire survey to the Gastroenterology Branch of the Liaoning Medical Association, China
por: Qi, Xingshun, et al.
Publicado: (2016)

Contrast-Enhanced CT May Be a Diagnostic Alternative for Gastroesophageal Varices in Cirrhosis with and without Previous Endoscopic Variceal Therapy
por: Li, Qianqian, et al.
Publicado: (2019)

Presumptive non‐cirrhotic bleeding esophageal varices in a dog
por: Myers, Marc, et al.
Publicado: (2018)

Dangers in using beta-blockers in patients with venovenous extracorporeal membrane oxygenation
por: Álvarez, Diego Rodríguez, et al.
Publicado: (2022)

Diagnostic Accuracy of APRI, AAR, FIB-4, FI, King, Lok, Forns, and FibroIndex Scores in Predicting the Presence of Esophageal Varices in Liver Cirrhosis: A Systematic Review and Meta-Analysis
por: Deng, Han, et al.
Publicado: (2015)

Non-cirrhotic Non-Wilsonian degeneration in antiphospholipid syndrome: Association or chance
por: Kumar, Sunil, et al.
Publicado: (2022)

Child-Na Score: A Predictive Model for Survival in Cirrhotic Patients with Symptomatic Portal Hypertension Treated with TIPS
por: Chen, Hui, et al.
Publicado: (2013)

Effectiveness and safety of four different beta‐blockers in patients with chronic heart failure
por: Liu, Baoshan, et al.
Publicado: (2023)

The Role of Non-Selective β-Blockers in Compensated Cirrhotic Patients without Major Complications
por: Yeh, Wen-Shuo, et al.
Publicado: (2019)

Systemic Mastocytosis Complicated by Non-Cirrhotic Portal Hypertension and Variceal Bleeding
por: McCarty, Thomas R., et al.
Publicado: (2017)

Risk Factors for Esophageal Collateral Veins in Cirrhosis with and without Previous Endoscopic Esophageal Variceal Therapy
por: Li, Qianqian, et al.
Publicado: (2022)

Fibrosis index predicts variceal bleeding and reduces need for nonselective beta-blocker in compensated cirrhosis with initial small esophageal varices without red-color sign
por: Wang, Sheng-Fu, et al.
Publicado: (2020)

Does Hepatic Impairment Influence Renal Function Parameters in Liver Cirrhosis?
por: Song, Tingxue, et al.
Publicado: (2018)

Disease-modifying medications in heart failure: more than ACE inhibitors and beta blockers
por: Chao, Chia-Ter
Publicado: (2011)

Is heart rate reduction more important than target dose in chronic heart failure therapy with a beta-blocker?
por: Guo, Yong-Fang, et al.
Publicado: (2011)

Role of Terlipressin in Cirrhotic Patients with Ascites and without Hepatorenal Syndrome: A Systematic Review of Current Evidence
por: Bai, Zhaohui, et al.
Publicado: (2020)

The secondary prophylactic efficacy of beta-blocker after endoscopic gastric variceal obturation for first acute episode of gastric variceal bleeding
por: Choi, Moon Han, et al.
Publicado: (2013)

Covered TIPS for secondary prophylaxis of variceal bleeding in liver cirrhosis: A systematic review and meta-analysis of randomized controlled trials
por: Qi, Xingshun, et al.
Publicado: (2016)

UK guidelines on the management of variceal haemorrhage in cirrhotic patients
por: Tripathi, Dhiraj, et al.
Publicado: (2015)

Pediatric Cirrhotic Variceal Bleed Precipitating Diabetic Ketoacidosis
por: Bridwell, Rachel E, et al.
Publicado: (2020)

Validation of the EVendo score for the prediction of varices in cirrhotic patients
por: Alswat, Khalid, et al.
Publicado: (2022)

Noninvasive Predictors of High-Risk Varices in Patients with Non-Cirrhotic Portal Hypertension
por: Cunningham, Morven E., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4lp5b2hak7rrbd9931fn9btm0r